Iridex (IRIX) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -11.64% |
| Jan 3, 2026 | -11.66% |
| Sep 27, 2025 | -14.24% |
| Jun 28, 2025 | -11.55% |
| Mar 29, 2025 | -10.67% |
| Dec 28, 2024 | -15.73% |
| Sep 28, 2024 | -15.82% |
| Jun 29, 2024 | -14.80% |
| Mar 30, 2024 | -11.72% |
| Dec 30, 2023 | 7.18% |
| Sep 30, 2023 | 7.09% |
| Apr 1, 2023 | 9.87% |
| Dec 31, 2022 | 6.70% |
| Oct 1, 2022 | 7.73% |
| Jul 2, 2022 | 5.85% |
| Apr 2, 2022 | 5.70% |
| Jan 1, 2022 | 5.32% |
| Oct 2, 2021 | 5.10% |
| Jul 3, 2021 | 12.86% |
| Apr 3, 2021 | 10.02% |
| Jan 2, 2021 | -12.43% |
| Sep 26, 2020 | -13.26% |
| Mar 28, 2020 | -13.31% |
| Dec 28, 2019 | -10.24% |
| Sep 28, 2019 | -5.58% |
| Jun 29, 2019 | -4.18% |
| Mar 30, 2019 | -1.35% |
| Dec 29, 2018 | -0.12% |
| Sep 29, 2018 | 2.31% |
| Jun 30, 2018 | -5.14% |
| Mar 31, 2018 | -4.14% |
| Dec 30, 2017 | -0.14% |
| Sep 30, 2017 | 10.21% |
| Jul 1, 2017 | 12.38% |
| Apr 1, 2017 | 12.87% |
| Dec 31, 2016 | 12.65% |
| Oct 1, 2016 | 10.06% |
| Jul 2, 2016 | 11.72% |
| Apr 2, 2016 | 13.27% |
| Jan 2, 2016 | 13.10% |
| Oct 3, 2015 | 10.12% |
| Jul 4, 2015 | 9.57% |
| Apr 4, 2015 | 10.97% |
| Jan 3, 2015 | 9.16% |
| Sep 27, 2014 | 1.82% |
| Jun 28, 2014 | 2.60% |
| Dec 28, 2013 | 4.85% |